Equities

Dswiss Inc

DQWS:PKC

Dswiss Inc

Actions
  • Price (USD)0.2929
  • Today's Change0.00 / 0.00%
  • Shares traded100.00
  • 1 Year change-94.66%
  • Beta--
Data delayed at least 15 minutes, as of Oct 04 2022 18:23 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

DSwiss, Inc. is a biotech-nutraceutical company, which is focused on supplying health and beauty products, including beverages to assist in weight management, and anti-aging creams. Its products include DSwiss Coffee, DSwiss Kiwi, DSwiss Triple SC, DSwiss Silk Mask, DSwiss Coffee Slimming Scrub, DSwiss Peppermint Slimming Gel, DSwiss New Age Essence, DSwiss Enlighten Essence (EE) Cream, SuiSu Hand Purifier and Sanitiser, SuiSu Air Sanitiser, SkinEra, DSwiss BioSpec, Genmune-Pro, and SensiBath. It provides medical consumables, which includes Surgical Gowns, 3-ply Face Masks, N95 Masks, Surgical Gloves, Protective Goggles, Body Infrared Thermometer, and Disposable Bedsheet and Stretcher Cover. Its Original Equipment Manufacturer and Original Design Manufacturer services products include Yumeka Hair Shampoo and Conditioner, MasterLiv, MasterHeart, WellG, and DNA Microarray Genotyping. It supplies its products in Malaysia, Singapore, Thailand, Indonesia, Hong Kong, and China.

  • Revenue in USD (TTM)2.60m
  • Net income in USD133.59k
  • Incorporated2015
  • Employees9.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Agile Therapeutics Inc6.69m-64.12m57.46m30.00--1.03--8.59-21.55-21.552.070.27660.15724.204.11222,933.30-150.67-78.25-286.92-97.00-81.97---958.69-3,988.370.5604-17.650.787--447.53---44.44--54.06--
ImmunoCellular Therapeutics Ltd0.00-4.93m57.77m3.00---------0.0435-0.04350.00-0.0212------0.00---126.34---171.37------------7.41-------254.37------
Correlate Infrastructure Partners Inc403.55k-2.68m57.98m11.00------143.68-0.0825-0.08250.007-0.01320.2844-------188.66-65.78----20.2631.50-663.41-195.160.3337-2.291.82---42.33-40.1251.05------
Mystic Holdings Inc-100.00bn-100.00bn59.10m79.00--2.37----------0.2155------------------------0.2228--0.1849--199.82--34.32------
Gemini Therapeutics Inc0.00-58.70m59.24m31.00--0.5542-----1.36-1.360.002.470.00----0.00-41.08---43.83-------------418.400.0265-------8,745.42------
Atreca Inc0.00-109.63m59.43m105.00--0.5159-----2.91-2.910.002.990.00----0.00-50.79---54.29--------------0.00-------26.63------
Aquestive Therapeutics Inc49.90m-73.02m59.75m157.00------1.20-1.76-1.761.20-1.810.81024.393.19317,834.40-118.56-81.64-207.11-120.7765.4968.58-146.34-92.681.30-2.47----10.87-0.3708-26.45---1.33--
Surface Oncology Inc30.55m-62.96m60.36m67.00--0.4582--1.98-1.29-1.290.62292.270.1529----455,925.40-31.52-16.81-34.87-19.57-----206.10-58.17---24.060.1676---97.87-16.53-232.27---32.17--
DSwiss Inc2.60m133.59k60.60m9.00450.62685.16297.6423.330.00070.00070.01260.00046.72118.5258.74288,663.3040.38-31.31300.35-85.6720.7828.776.01-19.450.974534.600.4281--45.3370.191,550.39--2.46--
ImmuCell Corporation20.46m273.41k60.81m64.00227.141.8622.162.970.03460.03462.634.230.4563.0411.81340,917.700.6095-2.740.642-2.9347.8646.861.34-7.115.072.140.2461--25.4315.0692.34---6.17--
Flora Growth Corp21.78m-48.76m61.18m162.00--0.9746--2.81-0.781-0.7810.36030.81580.39842.719.63---89.53---102.64--36.01---224.71--2.09-7.170.056--8,371.70---49.96------
X4 Pharmaceuticals Inc0.00-101.52m61.21m100.00--0.9189-----3.31-3.310.000.97040.00----0.00-84.03-60.56-99.77-67.97-------4,315.88---22.780.5239---100.00---65.20--53.15--
Longboard Pharmaceuticals Inc0.00-36.12m61.63m21.00--0.7403-----2.12-2.120.004.840.00----0.00-34.20---36.05--------------0.00-------93.03------
Pyxis Oncology Inc0.00-87.95m63.04m67.00--0.2942-----2.74-2.740.006.530.00----0.00-45.15---48.02-------------30.590.00-------492.26------
Data as of Oct 04 2022. Currency figures normalised to Dswiss Inc's reporting currency: US Dollar USD
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.